Ignite Creation Date:
2025-12-26 @ 10:59 AM
Ignite Modification Date:
2026-03-03 @ 6:09 AM
Study NCT ID:
NCT00802906
Status:
COMPLETED
Last Update Posted:
2012-09-27
First Post:
2008-12-04
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bevacizumab Versus Micropulse in Central Serous Chorioretinopathy (CSC)
Sponsor:
Johann Wolfgang Goethe University Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
MK-RCS-2008
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None